Cargando…
Pharmacological Tie2 activation in kidney transplantation
AIM: To investigate the therapeutic potential of vasculotide (VT) - a Tie2 activating therapeutic - in kidney transplantation. METHODS: We performed a murine MHC-mismatched renal transplant model (C57Bl/6 male into Balb/c female) with 60 min cold and 30 min warm ischemia time. 500 ng VT was administ...
Autores principales: | Thamm, Kristina, Njau, Florence, Van Slyke, Paul, Dumont, Daniel J, Park, Joon-Keun, Haller, Hermann, David, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036127/ https://www.ncbi.nlm.nih.gov/pubmed/27683636 http://dx.doi.org/10.5500/wjt.v6.i3.573 |
Ejemplares similares
-
The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis
por: Kümpers, Philipp, et al.
Publicado: (2011) -
Involvement of Angiopoietin-2 and Tie2 Receptor Phosphorylation in STEC-HUS Mediated by Escherichia coli O104:H4
por: Lukasz, Alexander, et al.
Publicado: (2015) -
Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis
por: Idowu, Temitayo O, et al.
Publicado: (2020) -
The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury
por: Rübig, Eva, et al.
Publicado: (2016) -
Optimization of adipose tissue-derived mesenchymal stromal cells transplantation for bone marrow repopulation following irradiation
por: Kim, Min-Jung, et al.
Publicado: (2022)